Zhejiang Wolwo Bio-Pharmaceutical News and Activities

Zhejiang Wolwo Bio-Pharmaceutical is a company listed under the stock ticker 300357 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at Zhejiang Wolwo Bio-Pharmaceutical

• Jianming He, General Manager
• Yanni Chen, Director
• Guoliang Xu, Independent Director

Create your alert
to follow the executive moves at Zhejiang Wolwo Bio-Pharmaceutical.

Zhejiang Wolwo Bio-Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Zhejiang Wolwo Bio-Pharmaceutical

Social media about Zhejiang Wolwo Bio-Pharmaceutical

• Zhejiang Wolwo Bio-Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Zhejiang Wolwo Bio-Pharmaceutical on LinkedIn, X (Twitter) & YouTube